COMMUNIQUÉS West-GlobeNewswire

-
Ultragenyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025 -
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
06/01/2025 -
Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
06/01/2025 -
Denali Therapeutics Announces Topline Results for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
06/01/2025 -
HWH International Inc. Announces Closing of Approximately $1.76 Million Public Offering at $0.40 per Share
06/01/2025 -
ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025 -
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
06/01/2025 -
Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025 -
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
06/01/2025 -
Revolution Medicines to Present at 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025 -
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025 -
CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update
06/01/2025 -
Oncocyte Expands Market Opportunity for VitaGraft™ Kidney
06/01/2025 -
Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025 -
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/01/2025 -
Cytokinetics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025 -
ACELYRIN, INC. Announces Additional Phase 2 Data and Phase 3 Program Design for Lonigutamab in Thyroid Eye Disease
06/01/2025 -
MESA LABS DECLARES QUARTERLY DIVIDEND
06/01/2025 -
Bright Peak Therapeutics to Participate in 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025
Pages